Abstract

Stem cell therapy represents a transformative approach to treating diabetes, offering potential solutions that extend beyond conventional management strategies. This abstract explores the current landscape of stem cell research and its application in diabetes treatment, focusing on bridging the gap between experimental research and real-world clinical solutions. Key areas of investigation include the development of stem cell-derived pancreatic beta cells for replacement therapy, strategies to enhance beta-cell regeneration, immune modulation to prevent autoimmune destruction in Type 1 diabetes, and innovative gene-editing techniques to correct underlying genetic defects. Despite significant advances, challenges such as safety concerns, scalability, and regulatory hurdles remain. Addressing these issues through rigorous research, clinical trials, and collaborative efforts is crucial for translating stem cell therapies into practical, accessible treatments. This synthesis highlights the promise of stem cell therapy in revolutionizing diabetes care while underscoring the need for continued progress to bridge research findings with tangible, real-world applications.